156 related articles for article (PubMed ID: 23636797)
1. CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls.
Qian J; Song Z; Lv Y; Huang X
Tumour Biol; 2013 Aug; 34(4):2225-31. PubMed ID: 23636797
[TBL] [Abstract][Full Text] [Related]
2. CYP2E1 polymorphisms and colorectal cancer risk: a HuGE systematic review and meta-analysis.
Jiang O; Zhou R; Wu D; Liu Y; Wu W; Cheng N
Tumour Biol; 2013 Apr; 34(2):1215-24. PubMed ID: 23355335
[TBL] [Abstract][Full Text] [Related]
3. CYP2E1 RsaI and 96-bp insertion genetic polymorphisms associated with risk for colorectal cancer.
Silva TD; Felipe AV; Pimenta CA; Barão K; Forones NM
Genet Mol Res; 2012 Sep; 11(3):3138-45. PubMed ID: 23007992
[TBL] [Abstract][Full Text] [Related]
4. Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.
Peng H; Xie SK; Huang MJ; Ren DL
Tumour Biol; 2013 Aug; 34(4):2389-95. PubMed ID: 23595220
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
Morita M; Le Marchand L; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Imaizumi N
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):235-41. PubMed ID: 19124503
[TBL] [Abstract][Full Text] [Related]
6. CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls.
Niu Y; Yuan H; Leng W; Pang Y; Gu N; Chen N
Med Oncol; 2011 Mar; 28(1):182-7. PubMed ID: 20195803
[TBL] [Abstract][Full Text] [Related]
7. Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.
Ye XH; Song L; Peng L; Bu Z; Yan SX; Feng J; Zhu XL; Liao XB; Yu XL; Yan D
Mol Genet Genomics; 2015 Apr; 290(2):545-58. PubMed ID: 25336053
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study.
Morita M; Tabata S; Tajima O; Yin G; Abe H; Kono S
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1800-7. PubMed ID: 18628434
[TBL] [Abstract][Full Text] [Related]
9. CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking.
Gao CM; Takezaki T; Wu JZ; Chen MB; Liu YT; Ding JH; Sugimura H; Cao J; Hamajima N; Tajima K
World J Gastroenterol; 2007 Nov; 13(43):5725-30. PubMed ID: 17963298
[TBL] [Abstract][Full Text] [Related]
10.
Fernandes GM; Russo A; Proença MA; Gazola NF; Rodrigues GH; Biselli-Chicote PM; Silva AE; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
World J Gastroenterol; 2016 Dec; 22(45):9974-9983. PubMed ID: 28018104
[TBL] [Abstract][Full Text] [Related]
11. Association of CYP2E1 gene polymorphisms with bladder cancer risk: A systematic review and meta-analysis.
Yin X; Xiong W; Wang Y; Tang W; Xi W; Qian S; Guo Y
Medicine (Baltimore); 2018 Sep; 97(39):e11910. PubMed ID: 30278485
[TBL] [Abstract][Full Text] [Related]
12. CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis.
Niu Y; Hu Y; Wu M; Jiang F; Shen M; Tang C; Chen N
Mol Biol Rep; 2012 Jan; 39(1):607-12. PubMed ID: 21553050
[TBL] [Abstract][Full Text] [Related]
13. Role of CYP2E1 genotypes in susceptibility to colorectal cancer in the Kashmiri population.
Sameer AS; Nissar S; Qadri Q; Alam S; Baba SM; Siddiqi MA
Hum Genomics; 2011 Oct; 5(6):530-7. PubMed ID: 22155602
[TBL] [Abstract][Full Text] [Related]
14. A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.
Cao L; Lin J; He B; Wang H; Rao J; Liu Y; Zhang X
Tumour Biol; 2014 Jan; 35(1):455-62. PubMed ID: 23934444
[TBL] [Abstract][Full Text] [Related]
15. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
Deng XD; Gao Q; Zhang B; Zhang LX; Zhang W; Mu Er ZE; Xie Y; Ma Y; Liu Y
Asian Pac J Cancer Prev; 2014; 15(12):4977-82. PubMed ID: 24998574
[TBL] [Abstract][Full Text] [Related]
16. CYP2E1 Rsa Ι/Pst Ι polymorphism and lung cancer susceptibility: a meta-analysis involving 10,947 subjects.
Shen ZT; Wu XH; Li B; Shen JS; Wang Z; Li J; Zhu XX
J Cell Mol Med; 2015 Sep; 19(9):2136-42. PubMed ID: 25945422
[TBL] [Abstract][Full Text] [Related]
17. CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis.
Guo Y; Zhou S; Liu F; Zhang B
Int J Clin Exp Pathol; 2015; 8(11):14685-92. PubMed ID: 26823792
[TBL] [Abstract][Full Text] [Related]
18. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.
Zhou GW; Hu J; Li Q
World J Gastroenterol; 2010 Jun; 16(23):2949-53. PubMed ID: 20556843
[TBL] [Abstract][Full Text] [Related]
19. The polymorphism of CYP2E1 Rsa I/Pst I gene and susceptibility to respiratory system cancer: a systematic review and meta-analysis of 34 studies.
Xu L; Yang M; Zhao T; Jin H; Xu Z; Li M; Chen H
Medicine (Baltimore); 2014 Dec; 93(27):e178. PubMed ID: 25501063
[TBL] [Abstract][Full Text] [Related]
20. CYP2E1 RsaI/PstI polymorphism and liver cancer risk among east Asians: a HuGE review and meta-analysis.
Tian Z; Li YL; Zhao L; Zhang CL
Asian Pac J Cancer Prev; 2012; 13(10):4915-21. PubMed ID: 23244081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
